{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:49:03Z","timestamp":1791982143629,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.spen.2026.101320","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:41:14Z","timestamp":1782924074000},"page":"101320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Symptomatic management of NORSE\/FIRES: Acute and chronic anti-seizure treatment"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4576-3293","authenticated-orcid":false,"given":"Jennifer V.","family":"Gettings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8727-3527","authenticated-orcid":false,"given":"Richard B.","family":"Carozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-640X","authenticated-orcid":false,"given":"Coral M.","family":"Stredny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2026.101320_bib0001","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based Guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.spen.2026.101320_bib0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1474-4422(24)00430-7","article-title":"Diagnosis and management of status epilepticus: improving the status quo","volume":"24","author":"Gettings","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2026.101320_bib0003","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaneurol.2024.0108","article-title":"Treatment of refractory status epilepticus with continuous intravenous anesthetic drugs: a systematic review","volume":"81","author":"Au","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.spen.2026.101320_bib0004","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00415-016-8074-7","article-title":"Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety","volume":"263","author":"Bellante","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.spen.2026.101320_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12028-010-9445-z","article-title":"A randomized trial for the treatment of refractory status epilepticus","volume":"14","author":"Rossetti","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.spen.2026.101320_bib0006","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101320_bib0007","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1474-4422(11)70187-9","article-title":"Management of refractory status epilepticus in adults: still more questions than answers","volume":"10","author":"Rossetti","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2026.101320_bib0008","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1177\/0883073816661458","article-title":"Propofol is mitochondrion-toxic and may unmask a mitochondrial disorder","volume":"31","author":"Finsterer","year":"2016","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2026.101320_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.154098","article-title":"The incidence of propofol infusion syndrome in critically-ill patients","volume":"71","author":"Li","year":"2022","journal-title":"J Crit Care"},{"key":"10.1016\/j.spen.2026.101320_bib0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.wnl.0000173066.89001.f9","article-title":"Propofol and thiopental for refractory status epilepticus in children","volume":"65","author":"Van Gestel","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2026.101320_bib0011","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.seizure.2023.09.008","article-title":"Febrile infection-related epilepsy syndrome in childhood: a clinical review and practical approach","volume":"111","author":"van Baalen","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.spen.2026.101320_bib0012","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1212\/WNL.38.7.1035","article-title":"Very-high-dose phenobarbital for refractory status epilepticus in children","volume":"38","author":"Crawford","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2026.101320_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2025.155347","article-title":"Is ketamine safe for traumatic brain injury? A systematic review and meta-analysis","volume":"91","author":"Sciorilli","year":"2026","journal-title":"J Crit Care"},{"key":"10.1016\/j.spen.2026.101320_bib0014","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/epi.17550","article-title":"Ketamine as advanced second-line treatment in benzodiazepine-refractory convulsive status epilepticus in children","volume":"64","author":"Buratti","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101320_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2017.04.019","article-title":"Simultaneous triple therapy for the treatment of status epilepticus","volume":"104","author":"Niquet","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"Suppl 2","key":"10.1016\/j.spen.2026.101320_bib0016","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/epi.14494","article-title":"Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: a single-center audit of 30 patients","volume":"59","author":"Rohracher","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101320_bib0017","article-title":"International consensus recommendations for management of new onset refractory status epilepticus (NORSE) including Febrile infection-related epilepsy syndrome (FIRES): summary and clinical tools","author":"Wickstrom","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101320_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10040881","article-title":"Pearls and pitfalls of introducing ketogenic diet in adult status epilepticus: a practical guide for the intensivist","volume":"10","author":"Katz","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.spen.2026.101320_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/epi4.70284","article-title":"Ketogenic diet therapy for children with super-refractory status epilepticus in intensive care: international clinical practice recommendations","author":"Blackford","year":"2026","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.spen.2026.101320_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00423","article-title":"Ketogenic diet as a treatment for super-refractory status epilepticus in Febrile infection-related epilepsy syndrome","volume":"10","author":"Peng","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.spen.2026.101320_bib0021","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the international ketogenic diet study group","volume":"3","author":"Kossoff","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.spen.2026.101320_bib0022","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pediatrneurol.2023.08.031","article-title":"Propofol for anesthesia in pediatric patients with epilepsy on the ketogenic diet: a single-center experience","volume":"149","author":"Bui","year":"2023","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2026.101320_bib0023","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.seizure.2015.09.007","article-title":"Concomitant lamotrigine use is associated with decreased efficacy of the ketogenic diet in childhood refractory epilepsy","volume":"32","author":"Van Der Louw","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.spen.2026.101320_bib0024","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/jcpt.12578","article-title":"Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy","volume":"42","author":"Heo","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.spen.2026.101320_bib0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(26)00008-6","article-title":"From clinical practice to mechanistic insights in ketogenic diets for epilepsy","volume":"25","author":"Figueroa","year":"2026","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2026.101320_bib0026","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cell.2018.06.051","article-title":"The gut microbiota mediates the anti-seizure effects of the ketogenic diet","volume":"174","author":"Olson","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.spen.2026.101320_bib0027","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.spen.2026.101320_bib0028","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2174\/1570159X20666220420130109","article-title":"Insights into the cellular interactions and molecular mechanisms of ketogenic diet for comprehensive management of epilepsy","volume":"20","author":"Kumar","year":"2022","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.spen.2026.101320_bib0029","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa1608193","article-title":"Hypothermia for neuroprotection in convulsive status epilepticus","volume":"375","author":"Legriel","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2026.101320_bib0030","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/WNP.0000000000000710","article-title":"Neuromodulation in super-refractory status epilepticus","volume":"38","author":"Stavropoulos","year":"2021","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.spen.2026.101320_bib0031","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1528-1167.2011.03350.x","article-title":"Long-term follow-up of febrile infection-related epilepsy syndrome","volume":"53","author":"Howell","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101320_bib0032","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2006.01.002","article-title":"Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis","volume":"69","author":"Mikaeloff","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.spen.2026.101320_bib0033","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-0404.2009.01198.x","article-title":"Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis","volume":"121","author":"Sakuma","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.spen.2026.101320_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1095061","article-title":"Seizure burden and neuropsychological outcomes of new-onset refractory status epilepticus: systematic review","volume":"14","author":"Taraschenko","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.spen.2026.101320_bib0035","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/epi.17241","article-title":"International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions","volume":"63","author":"Specchio","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101320_bib0036","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1111\/epi.18260","article-title":"Age-associated differences in FIRES: characterizing prodromal presentation and long-term outcomes via the web-based NORSE\/FIRES Family Registry","volume":"66","author":"Kazazian","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101320_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.110236","article-title":"Navigating life after New-onset refractory status epilepticus (NORSE) and Febrile infection-related epilepsy syndrome (FIRES): insights from caregiver and patient interviews","volume":"163","author":"Eschbach","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.spen.2026.101320_bib0038","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0883073816669450","article-title":"Cannabidiol as a potential treatment for Febrile infection-related epilepsy syndrome (FIRES) in the acute and chronic phases","volume":"32","author":"Gofshteyn","year":"2017","journal-title":"J Child Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.spen.2026.101320_bib0039","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/epi.14494","article-title":"Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: a single-center audit of 30 patients","volume":"59","author":"Rohracher","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101320_bib0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/ph17010028","article-title":"Efficacy of Perampanel in refractory and super-refractory status epilepticus with suspected inflammatory etiology: a case series","volume":"17","author":"Nilo","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.spen.2026.101320_bib0041","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1007\/s00415-021-10506-9","article-title":"Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review","volume":"268","author":"Lim","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.spen.2026.101320_bib0042","first-page":"1","article-title":"Vagus nerve stimulation (VNS) in super refractory new onset refractory status epilepticus (NORSE)","volume":"2019","author":"Kurukumbi","year":"2019","journal-title":"Case Rep Neurol Med"},{"key":"10.1016\/j.spen.2026.101320_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2017.02.011","article-title":"New-onset refractory status epilepticus treated with vagus nerve stimulation: a case report","volume":"47","author":"Yamazoe","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.spen.2026.101320_bib0044","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00381-021-05410-6","article-title":"Vagus nerve stimulation for super-refractory status epilepticus in febrile infection-related epilepsy syndrome: a pediatric case report and literature review","volume":"38","author":"Luo","year":"2022","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.spen.2026.101320_bib0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/epi.14684","article-title":"The spectrum of neuroimaging findings in febrile infection-related epilepsy syndrome (FIRES): a literature review","volume":"60","author":"Culleton","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101320_bib0046","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2020.04.015","article-title":"Efficacy of different treatment modalities for acute and chronic phases of the febrile infection-related epilepsy syndrome: a systematic review","volume":"79","author":"Kessi","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.spen.2026.101320_bib0047","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/epi4.12317","article-title":"Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome","volume":"4","author":"Dilena","year":"2019","journal-title":"Epilepsia Open"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909126000641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909126000641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:06:39Z","timestamp":1791979599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909126000641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"alternative-id":["S1071909126000641"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2026.101320","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptomatic management of NORSE\/FIRES: Acute and chronic anti-seizure treatment","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2026.101320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101320"}}